Cargando…
First person – Ling Wang
First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Ling Wang is first author on ‘ NANOG and LIN28 dramatically improve human cell reprogramming by modulating LIN...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918755/ http://dx.doi.org/10.1242/bio.049643 |
_version_ | 1783480654451703808 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Ling Wang is first author on ‘ NANOG and LIN28 dramatically improve human cell reprogramming by modulating LIN41 and canonical WNT activities’, published in BiO. Ling is a postdoc in the lab of Dr Young Tang at the University of Connecticut, USA, investigating somatic cell reprogramming and mechanisms of induced pluripotency for humans and large farm animal cells. |
format | Online Article Text |
id | pubmed-6918755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-69187552019-12-20 First person – Ling Wang Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Ling Wang is first author on ‘ NANOG and LIN28 dramatically improve human cell reprogramming by modulating LIN41 and canonical WNT activities’, published in BiO. Ling is a postdoc in the lab of Dr Young Tang at the University of Connecticut, USA, investigating somatic cell reprogramming and mechanisms of induced pluripotency for humans and large farm animal cells. The Company of Biologists Ltd 2019-12-05 /pmc/articles/PMC6918755/ http://dx.doi.org/10.1242/bio.049643 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Ling Wang |
title | First person – Ling Wang |
title_full | First person – Ling Wang |
title_fullStr | First person – Ling Wang |
title_full_unstemmed | First person – Ling Wang |
title_short | First person – Ling Wang |
title_sort | first person – ling wang |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918755/ http://dx.doi.org/10.1242/bio.049643 |